Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04340765Completed
Open-label, single-arm trial, sponsored by Buddhist Tzu Chi General Hospital. Primary endpoints: Sensitivity of 18F-fluorocholine PET/CT and NaF PET/CT at 6 weeks and Specificity of 18F-fluorocholine PET/CT and NaF PET/CT at 6 weeks. Started Feb 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04340765.